Platelet factor 4 (PF4) is identified as a marker for fibrosis, levels of which are elevated in patients with systemic sclerosis and correlated with the presence and progression of pulmonary arterial hypertension [7]. This evidence concerns the gene PF4 and pulmonary arterial hypertension.